Blood Clot Risk from COVID-19 Higher than After Vaccines: Study
A COVID-19 diagnosis is associated with a 39-in-1-million chance of developing a rare blood clot condition, compared with about a 4-in-1-million chance after receiving the Pfizer or Moderna mRNA vaccines against the disease, according to a data analysis led by researchers at the University of Oxford. The study, posted Wednesday (April 14), has not yet been peer reviewed. The findings add weight to concerns that suspending the use of other vaccines, namely, AstraZeneca’s and Johnson & Johnson’s adenovirus vector–based shots, might not be worth the tradeoff of leaving people without prote...